| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/03/2009 | WO2009083520A3 Liquid oral florfenicol compositions which can be diluted in drinking water |
| 12/03/2009 | WO2009078978A3 Compositions containing polyglycidol-based polymers and uses thereof |
| 12/03/2009 | WO2009077741A3 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 12/03/2009 | WO2009075838A3 Treatment of menorrhagia with aromatase inhibitor |
| 12/03/2009 | WO2009071519A9 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 12/03/2009 | WO2009061770A3 Method of inhibiting abcg2 and related treatments |
| 12/03/2009 | WO2009061345A3 Targeting cdk4 and cdk6 in cancer therapy |
| 12/03/2009 | WO2009057079A3 Novel pyrimidine derivatives |
| 12/03/2009 | WO2009053854A3 Polymorphs of dasatinib and process for preparation thereof |
| 12/03/2009 | WO2009040512A3 Modulation of rsk |
| 12/03/2009 | WO2009035473A3 Method of treating binge eating disorder, obesity resulting from binge eating behavior and depressive disorders |
| 12/03/2009 | WO2009032888A3 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract |
| 12/03/2009 | WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 12/03/2009 | WO2009024429A3 Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| 12/03/2009 | WO2008155534A9 Neurosteroid compounds |
| 12/03/2009 | WO2008139235A8 Novel piperazine salts as d3/d2 antagonists |
| 12/03/2009 | WO2008133717A3 Method of preventing infections caused by community acquired methicillin-resistant staphylococcus aureus |
| 12/03/2009 | WO2008131057A3 Sustained release formulations of opioid and nonopioid analgesics |
| 12/03/2009 | WO2008131056A3 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 12/03/2009 | WO2008115469A3 Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
| 12/03/2009 | WO2008086971A9 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 12/03/2009 | WO2008073332A3 Creatine compositions for skin treatment |
| 12/03/2009 | WO2008026219A3 Novel polymorphs of rimonabant |
| 12/03/2009 | WO2007138334A3 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression |
| 12/03/2009 | US20090300778 Neutral Sphingomyelinase-E and Its Use |
| 12/03/2009 | US20090300776 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
| 12/03/2009 | US20090299268 Topical Aminolevulinic Acid-Photodynamic Therapy for the Treatment of Acne Vulgaris |
| 12/03/2009 | US20090299190 Ultrasound Molecular Sensors and Uses Thereof |
| 12/03/2009 | US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy |
| 12/03/2009 | US20090299066 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 12/03/2009 | US20090299060 Compounds and methods for inhibiting mitotic progression |
| 12/03/2009 | US20090299050 Multi-Arm Block Copolymers as Drug Delivery Vehicles |
| 12/03/2009 | US20090298950 Cyclopentane/cyclopentene aldehyde or ketone derivatives and their use as odorants |
| 12/03/2009 | US20090298949 Aminoalkylphenols, methods of using and making the same |
| 12/03/2009 | US20090298948 Colchicine compositions and methods |
| 12/03/2009 | US20090298947 Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| 12/03/2009 | US20090298946 Local Anesthetic Deactivation |
| 12/03/2009 | US20090298945 Aqueous Extracts from Monocotyledon Plants and Their Use in Cardioprotection |
| 12/03/2009 | US20090298944 Pharmaceutical composition |
| 12/03/2009 | US20090298943 Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders |
| 12/03/2009 | US20090298942 Animal composition |
| 12/03/2009 | US20090298941 Anti-adipocyte fatty acid-binding protein (ap2), anti-flap and anti-cyslt1 receptor herbal compositions |
| 12/03/2009 | US20090298940 All Natural Antifungal And Antimicrobial Composition And Method Thereof |
| 12/03/2009 | US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 12/03/2009 | US20090298938 Use of semi synthetic analogues of boswellic acids for anticancer activity |
| 12/03/2009 | US20090298937 Method for Inhibiting the Growth of Bacteria |
| 12/03/2009 | US20090298936 Method for energizing human beings |
| 12/03/2009 | US20090298935 Production And Use Of A Gaseous Vapor Disinfectant |
| 12/03/2009 | US20090298934 Diamidine Inhibitors of TDP1 |
| 12/03/2009 | US20090298933 Oral composition containing egcg and lycopene |
| 12/03/2009 | US20090298932 Composition and method for the treatment of neurological disorders |
| 12/03/2009 | US20090298931 Novel chromenone potassium channel blockers and uses thereof |
| 12/03/2009 | US20090298930 Methods For Purifying Trans-(-) Delta9-Tetrahydrocannabinol And Trans-(+)-Delta9-Tetrahydrocannabinol |
| 12/03/2009 | US20090298929 Novel natural cyclodextrin complexes |
| 12/03/2009 | US20090298928 Composition and method for scalp and hair treatment |
| 12/03/2009 | US20090298927 Thermal Extraction Method and Product |
| 12/03/2009 | US20090298926 Process for the purification 10-deacetybaccatine iii from 10-deacetyl-2-debenzoyl-2-pentenoylbaccatine iii |
| 12/03/2009 | US20090298925 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/03/2009 | US20090298924 Hydroxamic acid derivatives as inhibitors of hdac enzymatic activity |
| 12/03/2009 | US20090298923 Salicylate Conjugates Useful for Treating Metabolic Disorders |
| 12/03/2009 | US20090298920 Chimeric transfer rna and use thereof for the production of rna by a cell |
| 12/03/2009 | US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/03/2009 | US20090298917 Non-Viral Vector System For The Delivery Of Nucleic Acid Into The Lung |
| 12/03/2009 | US20090298916 Pharmaceutical compositions for treatment of microRNA related diseases |
| 12/03/2009 | US20090298915 Topical drug delivery |
| 12/03/2009 | US20090298914 RNA Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (SARS) Virus Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 12/03/2009 | US20090298912 Arginase II: A Target treatment of aging heart and heart failure |
| 12/03/2009 | US20090298911 Short interfering RNA sequences for prevention and treatment of viral infection; viricides |
| 12/03/2009 | US20090298910 Regulation of epigenetic control of gene expression |
| 12/03/2009 | US20090298909 Multiple RNA Polymerase III Promoter Expression Constructs |
| 12/03/2009 | US20090298908 Dmae as sole agent for the treatment of mild cognitive impairment |
| 12/03/2009 | US20090298907 Reacting 2-halo-1-(4-fluorophenyl)-2-phenone of formula II with 4-methyl-3-oxo-N-phenylpentamide; high purity and good yield; for the synthesis of atorvastatin |
| 12/03/2009 | US20090298906 Proteasome inhibitors |
| 12/03/2009 | US20090298905 Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof |
| 12/03/2009 | US20090298904 Novel peptides from actinomadura namibiensis |
| 12/03/2009 | US20090298901 (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime dihydrate and methods of its use |
| 12/03/2009 | US20090298900 Oxo-Imidazolyl Compounds |
| 12/03/2009 | US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders |
| 12/03/2009 | US20090298897 Treatment of Inflammatory Disorders With Triazole Compounds |
| 12/03/2009 | US20090298896 Activating agent for peroxisome proliferator activated receptor delta |
| 12/03/2009 | US20090298895 Use of thioproline in body weight reduction treatments |
| 12/03/2009 | US20090298894 Amino acid compounds |
| 12/03/2009 | US20090298893 Addition Salts of Tolperisone, Processes for Their Preparation and Use Thereof |
| 12/03/2009 | US20090298892 Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine |
| 12/03/2009 | US20090298891 Methods of Treating or Preventing Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents |
| 12/03/2009 | US20090298889 Pharmaceutical compositions containing 2-pyridone derivatives as effective components |
| 12/03/2009 | US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 12/03/2009 | US20090298885 Methylene urea derivatives |
| 12/03/2009 | US20090298884 Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same |
| 12/03/2009 | US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 12/03/2009 | US20090298882 Thioxoisoindoline compounds and compositions comprising and methods of using the same |
| 12/03/2009 | US20090298881 Water-Soluble Artemisinin Derivatives, Their Preparation Methods, the Pharmaceutical Compositions and the Use Thereof |
| 12/03/2009 | US20090298880 Methods for the administration of iloperidone |
| 12/03/2009 | US20090298879 Impurities of Donepezil |
| 12/03/2009 | US20090298878 Oxime compounds and the use thereof |
| 12/03/2009 | US20090298877 Salts of creatine imino sugar amides |
| 12/03/2009 | US20090298876 Modulators of atp-binding cassette transporters |
| 12/03/2009 | US20090298875 A Combination of Compounds, Which Can be Used in the Treatment of Respiratory Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
| 12/03/2009 | US20090298874 Bacterial atp synthase binding domain |
| 12/03/2009 | US20090298873 Methods of reducing microbial resistance to drugs |